search
Back to results

Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children (EPIPOP)

Primary Purpose

Cardiovascular Diseases, Arteriosclerosis, Atherosclerosis

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
pOpmètre®
Sphygmocor
Sponsored by
Nantes University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Cardiovascular Diseases focused on measuring Arterial stiffness, pulse wave velocity, Sphygmocor, applanation tonometry, pOpmètre, children, EPIPAGE cohort

Eligibility Criteria

4 Years - 8 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • children between 4 and 8 years old hospitalized in the Mother and Children Hospital in Nantes during the study period.

Exclusion Criteria:

  • Vasoconstrictor treatment,
  • compressive bandage on the measured area,
  • peripheral venous access on the measured side,
  • vascular surgery or pathology on the measured area,
  • significant pain or agitation,
  • parental or legal representative disapproval,
  • child disapproval.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Experimental

    Arm Label

    SphygmoCor®

    pOpmètre®

    Arm Description

    Outcomes

    Primary Outcome Measures

    Difference between the two simultaneous measurements of velocity of the pulse wave by the pOpmeter® and the Sphygmocor®.

    Secondary Outcome Measures

    Full Information

    First Posted
    November 23, 2016
    Last Updated
    December 9, 2016
    Sponsor
    Nantes University Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02991703
    Brief Title
    Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children
    Acronym
    EPIPOP
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2016
    Overall Recruitment Status
    Unknown status
    Study Start Date
    December 2016 (undefined)
    Primary Completion Date
    November 2017 (Anticipated)
    Study Completion Date
    November 2017 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Nantes University Hospital

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Arterial stiffness is an important marker of cardiovascular risk. It is measured by pulse wave velocity. The reference device to measure pulse wave velocity is the Sphygmocor which uses applanation tonometry. It is used in adults and children. An easier method called pOpmètre using saturation sensors is validated in adults but not in children. The objective of this study is to compare the pulse wave velocity values measured with the pOpmètre® with those of the SphygmoCor® to validate the pOpmètre in children between 4 and 8 years old.
    Detailed Description
    Prematurity is associated with an increased risk of developing cardio-vascular diseases in adulthood : a low birth weight linked to prematurity is correlated to a higher coronary disease mortality rate, a higher blood pressure level in adulthood, to abnormal glucose metabolism regulation, and to signs of nephron reduction. An independent marker of cardiovascular risk is arterial stiffness: it is associated with a higher risk of major cardiovascular events including stroke, acute coronary syndrome and complications of end-stage renal disease. It is measured by pulse wave velocity which is the gold standard in adulthood. Pulse wave velocity is also correlated to cardiovascular risk in childhood. National cohort EPIPAGE II is made of 4290 premature babies born in 2011. A study is scheduled at 5 years old and a half including a medical examination and a neuropsychological evaluation. An ancillary study lengthening medical consultation for 15 minutes is scheduled with 750 to 1000 of these children for a more precise vascular evaluation including pulse wave velocity. Different methods can be used to measure pulse wave velocity in children: these include applanation tonometry devices such as the SphygmoCor ® system. Its reference values are well known in adulthood and were determined more recently in childhood. It is the reference device but it is expensive, can be used only in expert health centres and time of measurement is long. In children, an easier-to-use and faster device would be more advantageous. The pOpmètre® uses 2 distal oxygen saturation sensors on finger and toe to deduce pulse wave velocity. This device has already been validated in adults. The aim of this study is to validate the pOpmètre in children between 4 and 8 years old. In that purpose, patients are installed in the supine position, at rest. The child's mensurations are measured. The two pOpmètre sensors are put on finger and toe. Blood pressure is measured by an armband on the right limb. Then another armband is put around the thigh and a tonometer is applied on the right carotid which allows pulse wave velocity measuring by the Sphygmocor. Pulse wave velocity is measured with the pOpmètre using the time delay between finger pulse signal and toe pulse signal. The values got with the two devices are compared using a Bland and Altman graph. The pOpmètre is considered to be validated if the 95% confidence interval of the bias is included between -0.5 m/sec and 0.5 m/sec that is about 10% of the normal value at that age (5.0 m/s +/-0.13).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cardiovascular Diseases, Arteriosclerosis, Atherosclerosis
    Keywords
    Arterial stiffness, pulse wave velocity, Sphygmocor, applanation tonometry, pOpmètre, children, EPIPAGE cohort

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    60 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    SphygmoCor®
    Arm Type
    Active Comparator
    Arm Title
    pOpmètre®
    Arm Type
    Experimental
    Intervention Type
    Device
    Intervention Name(s)
    pOpmètre®
    Intervention Description
    the pOpmètre® uses saturation sensors,
    Intervention Type
    Device
    Intervention Name(s)
    Sphygmocor
    Intervention Description
    the Sphygmocor uses applanation tonometry
    Primary Outcome Measure Information:
    Title
    Difference between the two simultaneous measurements of velocity of the pulse wave by the pOpmeter® and the Sphygmocor®.
    Time Frame
    Day One

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    4 Years
    Maximum Age & Unit of Time
    8 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: children between 4 and 8 years old hospitalized in the Mother and Children Hospital in Nantes during the study period. Exclusion Criteria: Vasoconstrictor treatment, compressive bandage on the measured area, peripheral venous access on the measured side, vascular surgery or pathology on the measured area, significant pain or agitation, parental or legal representative disapproval, child disapproval.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jean-Christophe ROZE, Pr
    Email
    jeanchristophe.roze@chu-nantes.fr
    First Name & Middle Initial & Last Name or Official Title & Degree
    Emma Allain-Launay, Dr
    Phone
    02 40 08 36 60
    Email
    emma.allainlaunay@chu-nantes.fr

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    16461839
    Citation
    Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006 Feb 7;113(5):664-70. doi: 10.1161/CIRCULATIONAHA.105.579342.
    Results Reference
    background
    PubMed Identifier
    19729599
    Citation
    Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, Jacobson M, Mahoney L, Mietus-Snyder M, Rocchini A, Steinberger J, McCrindle B; American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension. 2009 Nov;54(5):919-50. doi: 10.1161/HYPERTENSIONAHA.109.192639. Epub 2009 Sep 3. Erratum In: Hypertension. 2010 Sep;56(3):e36.
    Results Reference
    background
    PubMed Identifier
    24716860
    Citation
    Ancel PY, Goffinet F; EPIPAGE 2 Writing Group. EPIPAGE 2: a preterm birth cohort in France in 2011. BMC Pediatr. 2014 Apr 9;14:97. doi: 10.1186/1471-2431-14-97.
    Results Reference
    background
    PubMed Identifier
    20530030
    Citation
    Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J. 2010 Oct;31(19):2338-50. doi: 10.1093/eurheartj/ehq165. Epub 2010 Jun 7.
    Results Reference
    background
    PubMed Identifier
    20566959
    Citation
    Reusz GS, Cseprekal O, Temmar M, Kis E, Cherif AB, Thaleb A, Fekete A, Szabo AJ, Benetos A, Salvi P. Reference values of pulse wave velocity in healthy children and teenagers. Hypertension. 2010 Aug;56(2):217-24. doi: 10.1161/HYPERTENSIONAHA.110.152686. Epub 2010 Jun 21.
    Results Reference
    background
    PubMed Identifier
    26989504
    Citation
    Curcio S, Garcia-Espinosa V, Arana M, Farro I, Chiesa P, Giachetto G, Zocalo Y, Bia D. Growing-Related Changes in Arterial Properties of Healthy Children, Adolescents, and Young Adults Nonexposed to Cardiovascular Risk Factors: Analysis of Gender-Related Differences. Int J Hypertens. 2016;2016:4982676. doi: 10.1155/2016/4982676. Epub 2016 Feb 18.
    Results Reference
    background
    PubMed Identifier
    25682547
    Citation
    Alivon M, Vo-Duc Phuong T, Vignon V, Bozec E, Khettab H, Hanon O, Briet M, Halimi JM, Hallab M, Plichart M, Mohammedi K, Marre M, Boutouyrie P, Laurent S. A novel device for measuring arterial stiffness using finger-toe pulse wave velocity: Validation study of the pOpmetre(R). Arch Cardiovasc Dis. 2015 Apr;108(4):227-34. doi: 10.1016/j.acvd.2014.12.003. Epub 2015 Feb 11.
    Results Reference
    background
    PubMed Identifier
    32218581
    Citation
    Bichali S, Bruel A, Boivin M, Roussey G, Romefort B, Roze JC, Allain-Launay E. Simplified pulse wave velocity measurement in children: Is the pOpmetre valid? PLoS One. 2020 Mar 27;15(3):e0230817. doi: 10.1371/journal.pone.0230817. eCollection 2020.
    Results Reference
    derived
    Links:
    URL
    https://www.youtube.com/watch?v=4aFnQ_0_bOI
    Description
    Related Info
    URL
    http://www.axelife.fr/fr/index.php
    Description
    Related Info

    Learn more about this trial

    Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children

    We'll reach out to this number within 24 hrs